Sidley Advises Precision NeuroMed on Strategic Partnership with Brainlab SE

"Sidley Austin advised Precision NeuroMed Inc. (PNM) in a strategic joint development and commercialization agreement with Brainlab SE to develop a cloud-based, AI-enabled convection enhanced delivery (CED) treatment planning platform for brain therapies; Brainlab also received an equity interest in PNM."

Sidley Austin represented Precision NeuroMed Inc. (PNM) in its strategic partnership with Brainlab SE, assisting PNM in the transaction. Under a Joint Development and Commercialization Agreement, PNM and Brainlab will collaborate to develop and commercialize a cloud-based, AI-enabled treatment planning platform for convection enhanced delivery (CED) to the brain. The project is intended to create a CED Treatment Planning System to optimize and personalize drug distribution directly into brain tissue. The partnership combines Brainlab’s expertise in medical imaging digitalization and surgical workflow integration with PNM’s proprietary molecular flow simulation software. As part of the agreement, Brainlab has also received an equity interest in PNM. Sidley Austin represented Precision NeuroMed Inc. (PNM) with a team composed by: Joshua T. Hofheimer (Technology and Life Sciences Transactions); Collin J. Marshall (Technology and Life Sciences Transactions); Francesca Blythe (Privacy and Cybersecurity); Sheri Porath Rockwell (Privacy and Cybersecurity); Eleanor Dodding (Privacy and Cybersecurity); and Torrey Cope (Food, Drug and Medical Device).

Menu

Sidley Advises Precision NeuroMed on Strategic Partnership with Brainlab SE

Read the full story

Menu

Sidley Advises Precision NeuroMed on Strategic Partnership with Brainlab SE

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads